Validity of psoriatic arthritis and capture of disease modifying antirheumatic drugs in the health improvement network

Pharmacoepidemiology and Drug Safety

Volumn 23, Issue 9, 2014, Pages 918-922

  Ogdie, Alexis ^a   Alehashemi, Sara ^a   Love, Thorvardur Jon ^b   Jiang, Yihui ^a   Haynes, Kevin ^a   Hennessy, Sean ^a   Choi, Hyon ^c   Gelfand, Joel M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF ICELAND   (Iceland)

^c BOSTON UNIVERSITY   (United States)

Author keywords

Database; Disease modifying antirheumatic drug (DMARD); Pharmacoepidemiology; Psoriatic arthritis; The health improvement network; Validation

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; HYDROXYCHLOROQUINE; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; SALAZOSULFAPYRIDINE; ANTIRHEUMATIC AGENT;

ADULT; AGED; ARTICLE; CODING ALGORITHM; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROSS-SECTIONAL STUDY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GENERAL PRACTITIONER; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PATIENT CODING; PATIENT SELECTION; PREDICTIVE VALUE; PRESCRIPTION; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; VALIDITY; ALGORITHM; ARTHRITIS, PSORIATIC; CODING; ELECTRONIC HEALTH RECORD; FACTUAL DATABASE; MIDDLE AGED; STANDARDS; STATISTICS AND NUMERICAL DATA; VALIDATION STUDY;

ADULT; AGED; ALGORITHMS; ANTIRHEUMATIC AGENTS; ARTHRITIS, PSORIATIC; CLINICAL CODING; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; ELECTRONIC HEALTH RECORDS; FEMALE; GENERAL PRACTITIONERS; HUMANS; MALE; MEDICAL RECORDS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; SURVEYS AND QUESTIONNAIRES;

EID: 84921530330     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3677     Document Type: Article

References (15)

1. Siannis F, Farewell V, Cook R, Schentag C, Gladman D. Clinical and radiographic damage in psoriatic arthritis. Ann Rheum Dis 2006; 65(4): 478-481.
2. Gelfand JM, Gladman DD, Mease PJ, Smith N, Margolis DJ, Nijsten T. Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol 2005; 53(4): 573.
3. Love T, Gudbjornsson B, Gudjonsson J, Valdimarsson H. Psoriatic arthritis in Reykjavik, Iceland: prevalence, demographics, and disease course. J Rheumatol 2007; 34(10): 2082-2088.
4. Setty A, Choi H. Psoriatic Arthritis Epidemiology. Curr Rheumatol Rep 2007; 9: 449-454.
5. Lewis JD, Schinnar R, Bilker WB, Wang X, Strom BL. Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf 2007; 16: 393-401.
6. Ogdie A, Langan S, Parkinson J, Dattani H, Kostev K, Gelfand J. Medical Record Databases. In Pharmacoepidemiology (5th edn), Strom B, Kimmel S, Hennessy S (eds). Oxford, UK: Wiley-Blackwell, 2012; p. 224-243.
7. THIN Bibliography. Available at: http://csdmruk.cegedim.com/THINBibliography.pdf [2 October 2013].
8. Seminara NM, Abuabara K, Shin DB, et al. Validity of The Health Improvement Network (THIN) for the study of psoriasis. Br J Dermatol 2011; 164(3): 602-609.
9. Ogdie A, Langan S, Love T, et al. Prevalence and treatment patterns of psoriatic arthritis in the United Kingdom. Rheumatology 2013; 52(3): 568-575.
10. The Health Improvement Network: Our Data. Available at: http://csdmruk.cegedim.com/our-data/our-data.shtml [2 October 2013].
11. Chishom J. The Read clinical classification. Br Med J 1990; 300: 1092.
12. Taylor W, Helliwell P. Classification Criteria for Psoriatic Arthritis: Development of New Criteria From a Large International Study. Arth Rheum 2006; 54: 2665-2673.
13. Ogdie A, Haynes K, Troxel AB, et al. Risk of mortality in patients with psoriatic arthritis, rheumatoid arthritis and psoriasis: a longitudinal cohort study. Ann Rheum Dis 2014; 73: 149-153.
14. Ibrahim G, Waxman R, Helliwell PS. The prevalence of psoriatic arthritis among patients with psoriasis. Arth Care & Research 2009; 61(10): 1373-1378.
15. Von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Epidemiology 2007; 18: 800-804.